Outlook Therapeutics, Inc.
$0.49
-0.01 (-2.36%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -28.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -58.4%
Own OTLK?
See how OTLK contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.